Yurou Xing Yongsheng Wang Xin Wu
10.3389/fonc.2023.1125226
Front Oncol
2023 May 15;13:1125226.
pd-1 inhibitor anaplastic thyroid carcinoma immunotherapy radiotherapy tislelizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/37256174/
Case Reports
PMC10225731
37256174
Radiotherapy combined with immunotherapy successfully treated one case of anaplastic thyroid cancer: A case report
2023